Literature DB >> 24385501

Tumor angiogenesis: putting a value on plastic GEMMs.

David A Cheresh1, Dwayne G Stupack.   

Abstract

Entities:  

Keywords:  Editorials; angiogenesis; focal adhesion kinases; genetically engineered mouse model; integrin aVb3; vascular endothelial cell growth factor

Mesh：

Substances：

Year:  2014        PMID： 24385501      PMCID： PMC4090242          DOI： 10.1161/CIRCRESAHA.113.302812

Source DB:  PubMed          Journal:  Circ Res        ISSN： 0009-7330            Impact factor:   17.367


× No keyword cloud information.
  26 in total

Review 1.  Discovery and development of bevacizumab, an anti-VEGF antibody for treating cancer.

Authors:  Napoleone Ferrara; Kenneth J Hillan; Hans-Peter Gerber; William Novotny
Journal:  Nat Rev Drug Discov       Date:  2004-05       Impact factor: 84.694

2.  Extensive vasculogenesis, angiogenesis, and organogenesis precede lethality in mice lacking all alpha v integrins.

Authors:  B L Bader; H Rayburn; D Crowley; R O Hynes
Journal:  Cell       Date:  1998-11-13       Impact factor: 41.582

Review 3.  Tumor angiogenesis: therapeutic implications.

Authors:  J Folkman
Journal:  N Engl J Med       Date:  1971-11-18       Impact factor: 91.245

4.  Integrin alpha(v)beta3 promotes M21 melanoma growth in human skin by regulating tumor cell survival.

Authors:  E Petitclerc; S Strömblad; T L von Schalscha; F Mitjans; J Piulats; A M Montgomery; D A Cheresh; P C Brooks
Journal:  Cancer Res       Date:  1999-06-01       Impact factor: 12.701

5.  Enhanced pathological angiogenesis in mice lacking beta3 integrin or beta3 and beta5 integrins.

Authors:  Louise E Reynolds; Lorenza Wyder; Julie C Lively; Daniela Taverna; Stephen D Robinson; Xiaozhu Huang; Dean Sheppard; Richard O Hynes; Kairbaan M Hodivala-Dilke
Journal:  Nat Med       Date:  2002-01       Impact factor: 53.440

6.  Decreased angiogenesis and arthritic disease in rabbits treated with an alphavbeta3 antagonist.

Authors:  C M Storgard; D G Stupack; A Jonczyk; S L Goodman; R I Fox; D A Cheresh
Journal:  J Clin Invest       Date:  1999-01       Impact factor: 14.808

Review 7.  Angiogenesis in cancer, vascular, rheumatoid and other disease.

Authors:  J Folkman
Journal:  Nat Med       Date:  1995-01       Impact factor: 53.440

8.  Definition of two angiogenic pathways by distinct alpha v integrins.

Authors:  M Friedlander; P C Brooks; R W Shaffer; C M Kincaid; J A Varner; D A Cheresh
Journal:  Science       Date:  1995-12-01       Impact factor: 47.728

9.  Integrin alpha v beta 3 antagonists promote tumor regression by inducing apoptosis of angiogenic blood vessels.

Authors:  P C Brooks; A M Montgomery; M Rosenfeld; R A Reisfeld; T Hu; G Klier; D A Cheresh
Journal:  Cell       Date:  1994-12-30       Impact factor: 41.582

10.  Apoptosis of adherent cells by recruitment of caspase-8 to unligated integrins.

Authors:  D G Stupack; X S Puente; S Boutsaboualoy; C M Storgard; D A Cheresh
Journal:  J Cell Biol       Date:  2001-10-29       Impact factor: 10.539
View more
  1 in total

1.  Novel Pure αVβ3 Integrin Antagonists That Do Not Induce Receptor Extension, Prime the Receptor, or Enhance Angiogenesis at Low Concentrations.

Authors:  Jihong Li; Yoshiyuki Fukase; Yi Shang; Wei Zou; José M Muñoz-Félix; Lorena Buitrago; Johannes van Agthoven; Yixiao Zhang; Ryoma Hara; Yuta Tanaka; Rei Okamoto; Takeshi Yasui; Takashi Nakahata; Toshihiro Imaeda; Kazuyoshi Aso; Yuchen Zhou; Charles Locuson; Dragana Nesic; Mark Duggan; Junichi Takagi; Roger D Vaughan; Thomas Walz; Kairbaan Hodivala-Dilke; Steven L Teitelbaum; M Amin Arnaout; Marta Filizola; Michael A Foley; Barry S Coller
Journal:  ACS Pharmacol Transl Sci       Date:  2019-08-02
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.